✦ LIBER ✦

Prevention of EAE in non-human primates by a type IV phosphodiesterase inhibitor that suppresses tumor necrosis factor

✍ Scribed by C.P. Genain; M.H. Nguyen; D. Faulds; A. Uccelli; R.L. Davis; J. Hedgpeth; S.L. Hauser

Book ID: 119108961
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 144 KB
Volume: 54
Category: Article
ISSN: 0165-5728
DOI: 10.1016/0165-5728(94)90326-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The specific type IV phosphodiesterase i

The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-α production by human mononuclear cells

✍ J. Semmler; H. Wachtell; S. Endres 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 374 KB

The specific type III and IV phosphodies

The specific type III and IV phosphodiesterase inhibitor zardaverine suppresses formation of tumor necrosis factor by macrophages

✍ F. Ulrich Schade; Christian Schudt 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 527 KB

Cicaprost and the type IV phosphodiester

Cicaprost and the type IV phosphodiesterase inhibitor, rolipram, synergize in suppression of tumor necrosis factor-α synthesis

✍ Tim F. Greten; Bhanu Sinha; Christiane Haslberger; Andreas Eigler; Stefan Endres 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 491 KB

Suppression of tumor necrosis factor α–i

Suppression of tumor necrosis factor α–induced matrix metalloproteinase 9 production in human salivary gland acinar cells by cepharanthine occurs via down-regulation of nuclear factor κB: A possible therapeutic agent for preventing the destruction of the acinar structure in the salivary glands of Sjögren's syndrome patients

✍ Masayuki Azuma; Keiko Aota; Tetsuya Tamatani; Katsumi Motegi; Tsuyoshi Yamashita 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 1 views